National Trends in Elective Ileal Pouch-Anal Anastomosis for Ulcerative Colitis by Hoang, Chau Maggie
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Dissertations and Theses Graduate School of Biomedical Sciences 
2018-06-05 
National Trends in Elective Ileal Pouch-Anal Anastomosis for 
Ulcerative Colitis 
Chau Maggie Hoang 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss 
 Part of the Digestive System Diseases Commons, Health Services Administration Commons, Health 
Services Research Commons, Surgery Commons, and the Surgical Procedures, Operative Commons 
Repository Citation 
Hoang CM. (2018). National Trends in Elective Ileal Pouch-Anal Anastomosis for Ulcerative Colitis. GSBS 
Dissertations and Theses. https://doi.org/10.13028/M27H74. Retrieved from 
https://escholarship.umassmed.edu/gsbs_diss/976 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and 
Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
NATIONAL TRENDS IN ELECTIVE ILEAL POUCH-ANAL ANASTOMOSIS  
FOR ULCERATIVE COLITIS 
 
A Master’s Thesis Presented 
 
By 
 
Chau Maggie Hoang, MD 
 
Submitted to the Faculty of the 
University of Massachusetts Graduate School of Biomedical Sciences, Worcester 
in partial fulfillment of the requirements for the degree of 
 
MASTER OF SCIENCE 
 
June 5, 2018 
 
BIOMEDICAL SCIENCES 
HEALTH SERVICES RESEARCH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
NATIONAL TRENDS IN ELECTIVE ILEAL POUCH-ANAL ANASTOMOSIS  
FOR ULCERATIVE COLITIS 
 
A Master’s Thesis Presented 
 
By 
 
Chau Maggie Hoang, MD 
 
The signatures of the Master’s Thesis Committee signify 
completion and approval as to style and content of the Thesis 
 
 
__________________________________ 
Robert Goldberg, PhD - Chair of Committee 
 
 
__________________________________ 
Karim Alavi, MD MPH - Thesis Advisor 
 
 
__________________________________ 
Jeremy Aidlen, MD - Member of Committee 
 
 
__________________________________ 
William Jesdale, PhD - Member of Committee 
 
 
 
The signature of the Dean of the Graduate School of Biomedical Sciences signifies that 
the student has met all master’s degree graduation requirements of the school. 
 
__________________________________ 
Mary Ellen Lane, PhD 
Dean of the Graduate School of Biomedical Sciences 
 
Program 
Master of Science in Clinical Investigation 
 
 June 5, 2018 
 3 
Acknowledgements 
 
First, I would like to acknowledge my thesis advisor, Dr. Karim Alavi, Director of 
Colorectal Research. I would not have been able to accomplish this and other works 
without his strong mentorship and continual guidance during my research years.  
 
I would also like to thank Dr. Jennifer Davids, Director of the Mark Kusek Colorectal 
Cancer Research Fellowship, for her strong mentorship and valuable advice during my 
research years.  
 
In addition, I would like to thank the Mark Kusek Colorectal Cancer Research Fellowship 
and the Surgical Research Scholars program for the opportunity to participate in 
research.  
 
I would also like to thank Dr. Maykel, Chief of the Division of Colon and Rectal Surgery, 
for allowing me the opportunity to contribute to the many on-going clinical projects in 
the division. 
 
I would also like to thank other contributors to this project, in addition to those above: 
Ms. Allison Wyman, for the acquisition of dataset and revision of this manuscript; Dr. 
Paul Sturrock, for revision of this manuscript. 
 
I would like to thank my Master’s Thesis Committee Members, Dr. Robert Goldberg, Dr. 
Jeremy Aidlen and Dr. William Jesdale for critical evaluation of my thesis project from 
proposal to completion. In addition, Dr. Goldberg provided continual guidance, 
encouragement and insightful critiques on all my projects throughout my two years in 
the MSCI program.  
 
I would also like to thank Dr. Kate Lapane and Ms. Kelley Barton for also helping me 
navigate the MSCI program.  
 
I would also like to thank Dr. Heena Santry and Ms. Kristie Capurso for all your support 
in helping me navigating the Surgical Research Scholars program. 
 
 
 
 
 
 
 
 
 4 
Abstract  
 
Background: Recent national trends and distribution of ileal pouch-anal anastomosis 
(IPAA) procedures for patients with ulcerative colitis (UC) are unknown. We examined 
the frequency of use of elective IPAA procedures among patients with UC and the 
distribution of IPAA procedures across more than 140 U.S. academic medical centers 
and their affiliates. 
Methods: Data were obtained from the University HealthSystem Consortium for 
patients with a primary diagnosis of UC admitted electively between 2012 and 2015.  
Results: The mean age of the study population (n=6,875) was 43 years and 57% were 
men. Among these, one-third (n=2,307) underwent an IPAA, while two-thirds (n=4,568) 
underwent colectomy, proctectomy, proctocolectomy or other procedures. The 
proportion of IPAA cases among all elective admissions was relatively stable at 33-35% 
during the years under study. A total of 131 hospitals, out of 279 hospitals participating 
in the UHC, performed IPAA. The median number of IPAA cases performed annually was 
1.9 [IQR 0.8 – 4.3]. Nearly one half (48%) of these cases were performed by the top ten 
hospitals. Overall, only a total of 30 centers performed  five elective IPAA cases 
annually.  
Conclusions: Although the frequency of elective IPAA surgery in recent years has been 
stable, nearly one half of all IPAA cases was performed at ten hospitals. The 
concentration of IPAA cases at high-volume centers, and the steady number of cases 
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performed annually, have potential implications for fellowship training, patient clinical 
outcomes and access to care. 
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CHAPTER I: Introduction 
   
The management of patients with ulcerative colitis (UC) has evolved in recent decades. 
Currently, the treatment of choice is medical management, which includes the use of 5-
aminosalicylic acid, corticosteroids, immunomodulators, tumor necrosis factor (TNF)- 
antagonists, and anti-integrin antibodies.1 Surgery is generally reserved for those who 
are refractory  to medical treatment, develop complications or experience severe side-
effects.1 Total proctocolectomy with end ileostomy, or restorative proctocolectomy with 
ileal pouch-anal anastomosis (IPAA), done in one, two, or three stages, are the 
mainstays of elective surgical management for UC.2 While there appears to be a trend 
toward better long-term outcomes for those with early disease after the introduction of 
biologics,3 there is no clear evidence that the rate of IPAA has decreased over time. 
A prior observational study evaluated trends in the 3-stage versus 2-stage 
approach for IPAA using data from the American College of Surgeons National Surgical 
Quality Improvement Program (ACS NSQIP).4 The investigators concluded that trends in 
the proportion of 3-stage vs 2-stage pouch procedures have remained relatively stable 
between 2007 and 2011. However, due to the sampling cycle of NSQIP, the overall 
number of IPAA procedures performed nationwide, and annual trends therein, could 
not be accurately determined. The minimum number of IPAA procedures for graduating 
colorectal surgical fellows is presently five and not all fellows regularly meet this 
requirement.5 This has led to a growing concern that either there is a decreasing trend 
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in the number of pouch procedures performed annually, potentially due to 
improvements in modifying the natural history of the disease, or that there is a 
redistribution of these surgical procedures to high-volume centers.  
We examined trends in the volume and distribution of elective IPAA procedures 
on patients with UC from 2012 to 2015 using information from the University 
HealthSystem Consortium (UHC) national database. Our primary study objective was to 
determine the frequency of IPAA pouch surgery cases performed in recent years among 
patients admitted electively with a primary diagnosis of UC. Our secondary aim was to 
describe the distribution of IPAA cases at the 140 participating academic centers and 
their affiliates in this large database. We hypothesized that there was either a decrease 
in the frequency of IPAA procedures performed among those admitted electively with a 
primary diagnosis of UC or that a large proportion of IPAA cases was being done at a 
small proportion of hospitals participating in the UHC.   
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CHAPTER II: Methods 
 
Data Source 
 
Data were obtained from the UHC, a national clinical database, on all adult patients 
admitted electively between January 2012 through August 2015 with a primary 
diagnosis of UC (ICD-9 556.X). A detailed description of this database has been 
previously reported.6 Data from the fourth quarter of 2015 and beyond were not 
included because a change in vendor during that interval affected the inclusion of all 
inpatient records into the database, and resulted in significant missing data for that 
quarter. Patient’s demographic data included their age, sex, race, and insurance carrier. 
Clinical data included hospital length of stay, intensive care unit stay and admission 3M 
APR-DRG Severity of Illness Score; this score, which is calculated upon admission based 
on existing comorbidities, is categorized as either minor, moderate, major, or extreme. 
Receipt of an IPAA procedure was identified using ICD-9 code 459.5, for adults admitted 
electively. Among those who were admitted electively but did not undergo an IPAA, ICD-
9 codes were used to identify performance of total abdominal colectomy or TAC (ICD-9 
458.1-458.3), partial colectomy (ICD-9 173.1-173.9, 457.1-457.9), proctectomy (486.3-
486.9,485.0-485.2, 485.9), or total proctocolectomy with end ileostomy (TAC with 
proctectomy and ICD-9 462.3). Among hospitals performing IPAA, we also identified the 
volume of low anterior resections (LAR; ICD-9 486.3) performed for rectal cancer (ICD-9 
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154.0-154.1, 154.8) in order to more clearly describe the practice patterns, specifically 
pertaining to complex pelvic dissections, observed among the included hospitals. In the 
UHC, all hospitals have unique de-identified hospital codes that cannot be linked back to 
individual hospitals, but the names of hospitals that contribute information to the 
database are known. The Institutional Review Board at the University of Massachusetts 
Medical School granted exemption status for this observational study. 
 
Outcome Measures 
 
The primary study outcome was the frequency of IPAA procedures performed among all 
elective admissions for UC at participating study sites during the period under study 
(2012-2015). Our secondary study endpoint was the distribution of elective IPAA cases 
across academic medical centers and their affiliates among patients with a primary 
admission diagnosis of UC. 
 
Data Analysis 
 
Univariate analysis was performed to compare differences in various clinical 
characteristics between patients with UC who did and did not undergo IPAA and the 
clinical characteristics and outcomes among the IPAA group across the different study 
years. Student’s t-test and analysis of variance were used for comparisons of continuous 
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data, and chi-square test was used for comparisons of categorical variables. 
Comparisons were considered statistically significant at an alpha level of 0.05. Hospitals 
in the study were sorted according to de-identified codes to determine the total and 
mean number of IPAA cases performed annually in patients with UC at each unique 
hospital. Imputed data for the fourth quarter of 2015 were used to verify no significant 
change in the calculated average number of procedures performed per hospital due to 
missing fourth quarter data. We imputed the total number of cases per hospital for 
2015 by dividing the reported number of cases for the first three quarters by 0.75. All 
statistical analyses were done using STATA version 14.2 (StataCorp. 2015. Stata 
Statistical Software: Release 14. College Station, TX: StataCorp LP). 
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CHAPTER III: Results 
 
Study Population Characteristics 
 
Between 2012 and 2015, a total of 6,875 patients were admitted electively with a 
primary diagnosis of UC. The mean age of this patient population was 43 years, 57% 
were men, 85% were white, and 73% had private insurance (Table 1). One-third 
(n=2,307) underwent an IPAA during the years under study. Among the non-IPAA group 
(n=4,568), the majority underwent either total abdominal colectomy (36%), 
proctectomy (25%), partial colectomy (7%) or total proctocolectomy with end ileostomy 
(2%).  Among those who underwent an IPAA, a higher proportion had private insurance 
and a smaller proportion had severe or extreme severity of illness score on admission 
compared with patients who did not undergo an IPAA (p=0.001).  
 
Trends in Elective IPAA Utilizations 
 
The frequency of IPAA among all elective admissions with a primary diagnosis of UC in 
adults was stable at 33-35% from 2012 to 2015 (Fig. 1). During the years under study, 
there was no significant change in patient’s average age, median length of hospital stay, 
severity of illness score, or in the proportion of patients requiring admission to the ICU 
among those who underwent an IPAA.  
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Distribution of Elective IPAA Cases 
 
Among the 279 hospitals in the UHC database, there were 131 hospitals that performed 
IPAA (Fig. 2). The median number of cases performed on an annual basis at these 
hospitals was 1.9 [IQR 0.8 – 4.3]. Nearly one half (48%) of the cases were performed by 
only ten hospitals (performing an average of 30 pouches procedures annually; range 
between 12 to 96 pouches annually). Overall, only a total of 30 centers (out of 131 
centers that performed IPAA) performed  5 elective IPAA cases per year.  
We reported results over the period from January 2012 to August 2015. To 
evaluate the effect of the missing fourth quarter data from 2015 on the calculated mean 
number of cases per center, we compared the results to a second dataset that included 
imputed data from the fourth quarter of 2015. Comparing our original findings with 
imputed data yielded no change in the number of centers performing  5 elective IPAA 
cases per year. 
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Distribution of LAR for Rectal Cancer 
 
Among the hospitals that performed IPAA procedures, we evaluated the distribution of 
low anterior resection (LAR) performed for rectal cancer at those centers. This 
additional step was performed to assess whether the skewed distribution was unique to 
IPAA cases alone or whether a similar distribution would be observed in other types of 
complex pelvic dissections and reconstruction procedure in colorectal surgery at these 
hospitals. 
 
The median number of LAR cases performed per center on an annual basis was 4 [IQR 
1.25-13.5]. The centers that performed higher annual volume (ten or more) of IPAA 
cases had a varied distribution in the annual number of LAR cases (Fig. 3). These centers 
performed from 6 LAR procedures to over 60 LAR procedures per year. Centers that 
performed a lower volume of IPAA (fewer than ten) cases annually also had a varied 
distribution in the annual number of LAR procedures, with some centers performing 
over 60 LAR procedures annually for rectal cancer (Fig. 3). The top ten centers that 
performed 48% of IPAA cases from 2012-2015 performed only 18% of total LAR cases.  
 
 
 
 
 17 
CHAPTER IV: Discussion 
 
The results of this study suggest that the frequency of IPAA surgery among elective 
admissions for UC remained stable during the years under study. Among the 279 
hospitals in the UHC, ten hospitals performed nearly one half of the elective IPAA cases 
nationally. Furthermore, our study suggests that many centers that perform a large 
number of complex pelvic dissections for rectal cancer are low-volume pouch centers. 
The disproportionate distribution of these case volumes has potential implications for 
patients’ clinical outcomes and overall access to care.  
It has been shown previously that the risk of pouch failure, defined as requiring 
excision or requiring permanent ileostomy,7 is more than two-fold higher at very low 
volume centers that perform 1-5 cases annually compared with high-volume centers 
that perform more than 20 cases annually.8 This observational study of 1991 patients 
from Denmark who underwent an IPAA from 1980-2013, with a median follow-up of 11 
years, determined the pouch failure rate of 9% at 5 years, 12% at 10 years and 18% at 
20 years.8 In another study of 4,525 patients who underwent an IPAA procedure 
between 1983 and 2015 at a single high-volume center in the US, with a median follow-
up of 10 years, the investigators observed a pouch failure rate of 4.8%.9 
While only a small percentage of centers performed a large proportion of all 
pouch procedures during the years under study in the present study, this pattern was 
not observed for other complex pelvic dissections. Whereas the majority of centers 
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included performed only a handful of IPAA procedures, many of these centers 
performed a significant number of total mesorectal excisions for rectal cancer. These 
data suggest that, despite a lower volume of pouch surgery, surgeons at these lower 
volume centers have the technical experience required to perform complex pelvic 
dissections. The reasons why many patients with UC are diverted away to certain 
centers for IPAA remain unclear. However, the direct association between these findings 
and complex pelvic procedure volume-outcome relationship as it relates to restorative 
proctocolectomy warrants further investigation. 
This study identified a disproportionate distribution of case volume which may 
have implications for surgical training. Only 60% of colon and rectal fellowship training 
programs participate in the UHC database.  Inasmuch, we cannot directly use UHC data 
to determine whether all surgical training programs are providing sufficient numbers of 
cases for their fellows; however, we can report on cases by graduating fellows and 
fellowship training programs. In 2013 and 2014, more than 35% of colon and rectal 
fellows did not meet the graduation requirement for the number of IPAA cases .5 In 
2015, 10% of colon and rectal training programs did not meet the IPAA case 
requirement; 12% (11/94) of fellows did not meet pouch procedure requirements of five 
cases per year, despite an overall reported national average of 8.4 cases per fellow for 
that year.5  In our study, the median number of IPAA procedures performed per year 
was 1.9 [IQR 0.8-4.3]. This discrepancy can be explained by the fact that almost half of 
the IPAA cases reported in the UHC database are performed by only ten academic 
 19 
centers. Despite the recent reduction in IPAA case requirement from 8 to 5 cases for 
fellowship training, meeting these requirement for graduation remains a focal point of 
concern for training programs and the American Board of Colon and Rectal Surgery.  
 
Study Strengths and Limitations 
 
A particular strength of this study is that UHC is a national database that contains all 
inpatient data on 90% of academic hospitals and their affiliates, allowing us to evaluate 
national trends and distribution of IPAA cases in patients with UC. This study is the first 
to evaluate the national distribution of IPAA procedures among patients with UC. 
Another strength of this study was an examination of the distribution of other complex 
pelvic dissections, in addition to IPAA, to determine any changes in the distribution of 
other complex pelvic dissections at participating study centers. This observational study, 
however, is not without limitations. Hospital codes in UHC are also de-identified; 
therefore, we were unable to identify specific high or low performing hospitals or their 
characteristics. Furthermore, zip code data were also not available, precluding an 
assessment of possible geographic differences in low-volume versus high-volume 
centers or referral patterns. We also did not study the short- and long-term clinical 
outcomes of these patients, as they were not the focus of this study, but future work 
comparing outcomes at higher- and lower-volume centers will offer a better 
understanding of quality of care for these patients.  
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CHAPTER V: Conclusions 
 
Although the frequency of elective IPAA surgery for patients with UC was stable 
between 2012 and 2015, nearly one-half of all IPAA cases was performed at only ten 
hospitals in the U.S. The large concentration of cases at select hospitals and the steady 
number of cases performed annually has potential implications not only for case 
requirements but also for the adequate provision of training in IPAA during colorectal 
fellowship across the country. Potential changes include decreasing the minimum 
number of IPAA case requirements for fellows in training or allowances for fellows to 
travel to high-volume performing centers for pouch cases. Further work should evaluate 
whether the concentration of IPAA cases at high-volume centers has implications for 
potential differences in patients’ clinical outcomes and access to care. 
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Tables 
 
Table 1. Characteristics of Patients with Ulcerative Colitis According to Ileal Pouch-
Anal Anastomosis (IPAA) Status 
 
Characteristics  IPAA (n=2,307)   Non-IPAA (n=4,568) p-value 
Age, mean, years (+/-SD) 40 (+/-14)  45 (+/-17) <0.001 
Male sex  56.7%  56.5% 0.87 
White race  86.3%  84.0% 0.01 
Insurance typea    0.001 
 Private 81.0%  69.2%  
 Medicare 6.3%  17.6%  
 Medicaid 7.8%  6.9%  
Admission Severity of Illness    0.001 
 Minor 10.6%  11.2%  
 Moderate 85.0%  76.9%  
 Severe/Extreme 4.4%  11.9%  
Length of Stay, median days (IQR) 5 (4-7)  5 (4-8)  
     
a“Other” not shown 
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Figures 
 
 
Figure 1. Trends in Frequency of Ileal Pouch-Anal Anastomosis Cases Among All 
Elective Admissions for Ulcerative Colitis  
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Figure 2. Distribution of Ileal Pouch-Anal Anastomosis (IPAA) Cases From 2012-2015 
by: A) Hospital Volume and B) Case Volume 
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Figure 3. Distribution of Low Anterior Resection (LAR) Cases for Rectal Cancer Among 
Hospitals That Performed Ileal Pouch-Anal Anastomosis (IPAA) Between 2012 and 
2015 
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